Form:
Nasal Spray
Concentration:
0.05%
Pack:
12 ml
Composition:
Mometasone Furoate
shelf life:
2 years
Metered Dose Nasal Spray.
Symptomatic treatment of seasonal or perennial rhinitis.
Can be used as prophylactic treatment in pollen season.
Effective relief of all nasal symptoms.
Potent anti-inflammatory effects.
Lowest systemic bioavailability of all intranasal corticosteroids (less than 0.1%).
Rapid onset of action (Within 5 Hrs).
Well tolerated in adult and pediatric patients.
No adverse effect on growth in children.
Safe to use for children aged 2 years and over.
Amman Pharmaceutical Industries (API) was established in 1989 as one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of Ophthalmology, ENT (Ear, Nose & Throat ) , respiratory, and Dermatology. After many years of success.
